Coloplast A/S
CLPBYOTCHealthcare● Active
$5.94
$-0.02(-0.34%)
Market Cap$13.4B
P/E Ratio—
52W High$10.03
52W Low$5.88
Coloplast A/S (CLPBY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CLPBY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $26.25B | $27.03B | $24.50B | $22.58B | $19.43B |
| Cost of Revenue | $9.17B | $8.76B | $8.17B | $7.05B | $6.11B |
| Gross Profit | $17.08B | $18.27B | $16.33B | $15.53B | $13.31B |
| Gross Margin %(computed) | 65.06% | 67.59% | 66.64% | 68.78% | 68.53% |
| Operating Expenses | |||||
| R&D Expenses | $0.85B | $0.91B | $0.87B | $0.87B | $0.76B |
| G&A Expenses | $0.00B | $1.24B | $1.11B | $1.00B | $0.76B |
| Total Operating Expenses | $9.94B | $10.95B | $9.48B | $8.62B | $6.96B |
| Operating Income | $7.14B | $7.32B | $6.77B | $6.44B | $6.36B |
| Operating Margin %(computed) | 27.19% | 27.08% | 27.64% | 28.52% | 32.71% |
| Interest Income | $0.10B | $0.15B | $0.11B | $0.01B | $0.01B |
| Interest Expense | $0.78B | $0.88B | $0.64B | $0.17B | $0.03B |
| Income Before Tax | $5.80B | $6.39B | $6.03B | $6.13B | $6.23B |
| Income Tax Expense | $2.38B | $1.34B | $1.24B | $1.42B | $1.41B |
| Net Income | $3.42B | $5.05B | $4.78B | $4.71B | $4.83B |
| Net Margin %(computed) | 13.05% | 18.69% | 19.52% | 20.84% | 24.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.52 | $2.25 | $2.22 | $2.22 | $2.27 |
| Wtd Avg Shares | 2.25B | 2.25B | 2.15B | 2.13B | 2.13B |
| EBITDA | $7.85B | $8.48B | $7.73B | $7.23B | $7.08B |
| EBITDA Margin %(computed) | 29.91% | 31.37% | 31.56% | 32.02% | 36.46% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · DKK · B
Explore more Coloplast A/S data
About Coloplast A/S (CLPBY) Income Statement
Coloplast A/S (CLPBY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CLPBY reported revenue of $26.25B, gross profit of $17.08B (gross margin 65.06%), and net income of $3.42B — a net profit margin of 13.05%.
Frequently asked questions
CLPBY · 4 questionsColoplast A/S (CLPBY) reported revenue of $26.25B for 2025, down 2.9% year-over-year.
CLPBY revenueCLPBY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09